ArticleAging2024

Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway.

Yanbin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.